| Application no. and date | 00937235.0 (espacenet) (Federated) (European Patent Register), 20000615 | | Patent/reg. no. and date | DK/EP 1129088, 20080402 | | Publication date | 20010905 | | Priority no. and date | JP 17150999, 19990617 | | EP pub. no. and date |
EP 1129088 20010905 | | Effective date | | | Applicant/owner | Takeda Pharmaceutical Company Limited, 1-1, Doshomachi 4-chome, Chuo-ku
Osaka 541-0045, JP | | Applicant ref. no. | 151844 | | Inventor | FUJISHIMA, Akira, 1-6, Fujigaoka 1-chome
Sanda-shi,
Hyogo 669-1547, JP,
KAMIYAMA, Keiji, 5-41, Matsugamoto-cho
Ibaraki-shi,
Osaka 567-0033, JP,
AOKI, Isao, 17-1, Daiwahigashi 3-chome
Kawanishi-shi,
Hyogo 666-0111, JP | | Representative | AWA Denmark A/S, Strandgade 56, 1401 København K, DK | | Opponent | | | IPC Class | A61K 31/44 (2006.01) , A61P 1/04 (2006.01) , C07D 401/12 (2006.01) | | Title | Krystallinsk form af (R)-2-[[[3-methyl-4-(2,2,2-trifluorethoxy)-2-pyridin-yl]methyl]sulfinyl]-1H-ben | | Int. application no. | JP2000003880 | | Int. publication no. | WO2000078745 | | Related patent (certificate) | | | Status | Udløbet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
